Mixed Hyperlipidemia
Metabolic
Mixed Hyperlipidemia is treated with 12 medications in our database, including Antara, FENOFIBRATE, ANTARA, Pravastatin sodium, ezetimibe and simvastatin, and 7 more. 12 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Lupin, AbbVie, Bristol Myers Squibb, Merck, Kowa and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Mixed Hyperlipidemia treatment below.
What help exists for Mixed Hyperlipidemia
13
drugs indexed
2
with copay cards
2
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Mixed Hyperlipidemia
13 totalTricor
Fenofibrate · AbbVie
FENOFIBRATE
Fenofibrate · AbbVie
Livalo
pitavastatin calcium · Kowa
FENOFIBRIC ACID DELAYED-RELEASE
FENOFIBRIC ACID · AbbVie
Zetia
Ezetimibe · Merck
🎟💙PRAVASTATIN SODIUM
PRAVASTATIN SODIUM
VYTORIN
ezetimibe and simvastatin · Organon
🎟💙Ezetimibe
EZETIMIBE · Merck
Antara
fenofibrate
Fluvastatin
Fluvastatin
FENOFIBRIC ACID
Fenofibric Acid · AbbVie
Lipofen
fenofibrate · Kowa
Ezetimibe and Simvastatin
Ezetimibe and Simvastatin · Actavis Pharma, Inc.
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Mixed Hyperlipidemia drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Showing 10 of 23 PA rules for Mixed Hyperlipidemia drugs. View individual drug pages for complete PA detail.